A single-center study reveals hypothyroidism impacts melanoma prognosis, suggesting it may play a protective role.
Our findings suggest that hypothyroidism is markedly more prevalent among patients with cutaneous melanoma and may be associated with clinical features linked to improved prognosis. These observations warrant further investigation to clarify whether hypothyroidism itself, or its underlying immunologic and hormonal milieu, plays a protective role in melanoma progression.
No takes yet. Share an insight, caveat, or question.
Klose et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: